# Catalent Germany Eberbach GmbH – FDA Inspection, Sep 6, 2019

Source: https://www.keypedia.com/records/fda_inspections/catalent-germany-eberbach-gmbh/d64a79a5-768c-4018-93dc-9cd292aeaaa9
Source feed: FDA_Inspections

> FDA inspection 1106613 of Catalent Germany Eberbach GmbH, September 06, 2019. Classification: No Action Indicated (NAI). 6 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1106613
- Company Name: Catalent Germany Eberbach GmbH
- Inspection Date: 2019-09-06
- Classification: No Action Indicated (NAI)
- Classification Code: NAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1255823 - 2024-02-02](https://www.keypedia.com/records/fda_inspections/catalent-germany-eberbach-gmbh/5a4da443-351c-4f3b-8bd1-0c11e78876e7)
- [FDA Inspection 1048712 - 2018-03-02](https://www.keypedia.com/records/fda_inspections/catalent-germany-eberbach-gmbh/f27409b9-09c8-4e11-88d6-eee186cf0664)
- FDA Inspection 989834 - 2016-03-18
- FDA Inspection 850147 - 2013-09-12
- FDA Inspection 818378 - 2013-02-08

## Related Officers

- [FDA Associated Person](https://www.keypedia.com/people/jessica-p-mcalister/d892c069-d283-4bb0-9cbb-78e463bfc1ea)

Company: https://www.keypedia.com/companies/catalent-germany-eberbach-gmbh/fcf97f2a-c54b-4105-afc0-11a0c999d8a5

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c